CA-19.9
CA-19.9 is a tumour marker commonly associated with pancreatic cancer. It can also be elevated in other gastrointestinal cancers and some non-cancerous conditions. No fasting is required.
12 hours
Turnaround
Blood
Sample
What the CA-19.9 test tells you
CA-19-9 is a carbohydrate structure carried on proteins and lipids made by the cells lining the pancreas, bile ducts, stomach and bowel. Small amounts reach the bloodstream normally. When those tissues are diseased, whether by a tumour or simply by inflammation and obstruction, much more is released, and that is what the blood test measures.
It is most closely associated with cancer of the pancreas, where it has three practical uses: helping assess a pancreatic mass that has already been found on imaging, giving an indication of prognosis before treatment, and following the disease during and after treatment. A falling value after surgery or chemotherapy supports response; a rising one prompts reassessment. It also has a role in cancers of the bile ducts and, less often, of the stomach and colon. It is not a screening test, and in people without symptoms it produces far more false alarms than useful findings.
Two things limit it heavily and both matter to anyone reading a result. The first is obstruction. Anything that blocks bile flow, whether a gallstone, an infected bile duct, or the tumour itself, raises CA-19-9 substantially without saying anything about how much cancer is present. Pancreatitis and jaundice from any cause do the same. A value taken while a person is jaundiced can badly mislead, and is usually repeated once the obstruction has been relieved. The second is genetic: producing this antigen requires an enzyme linked to the Lewis blood group system, and a well-recognised group of people simply do not have it. In them the test stays low no matter how advanced any disease might be, so it is uninformative for them entirely. For both reasons, a normal CA-19-9 never excludes pancreatic or biliary cancer, and the trend across repeated samples always means more than a single figure.
Used to monitor pancreatic cancer treatment response, assess prognosis, and aid in the differential diagnosis of pancreatic masses.
Serial values during and after treatment for pancreatic or biliary cancer show the direction the disease is moving, complementing imaging.
In follow-up after surgery, a sustained rise can suggest returning disease before it becomes visible on scans.
Alongside imaging and clinical findings, the value contributes to how a pancreatic or biliary mass that has already been found is managed.
A value taken before treatment, once any blockage of bile flow has been relieved, carries prognostic information for the treating team.
Reasons your doctor may request the CA-19.9 test
Your doctor may order this test for any of the reasons below. Some are routine checks, others follow specific symptoms or an earlier result.
Assessing a mass or jaundice
A pancreatic or biliary mass already identified on imaging that needs further assessment.
Unexplained jaundice or persistent upper abdominal pain, investigated alongside imaging.
Treatment response & surveillance
Monitoring response to surgery or chemotherapy in diagnosed pancreatic or biliary cancer.
Surveillance for recurrence after treatment of pancreatic cancer.
Follow-up of cholangiocarcinoma or, in selected cases, gastric or colorectal cancer.
No fasting window — pick any slot that suits you, online or on WhatsApp.
A DHA-licensed nurse collects your sample at home or in the office — free home collection.
A physician-reviewed, easy-to-read report lands securely by WhatsApp and email.
CA-19.9 is associated with pancreatic and GI conditions.
Ranges are a guide — your physician interprets your result alongside your symptoms and history.
What a higher result can point to
- Obstruction of bile flow from gallstones, strictures or infection of the bile ducts, which commonly produces marked elevations with no cancer present at all.
- Acute and chronic pancreatitis, cirrhosis, and jaundice from any cause.
- Pancreatic cancer, the malignancy with which it is most strongly associated.
- Cholangiocarcinoma and other cancers of the biliary tree.
- Gastric, colorectal and some ovarian and lung cancers.
- Benign conditions such as thyroid disease and bronchiectasis, less commonly.
These are possibilities, not diagnoses. A single value outside the reference range is interpreted alongside your symptoms, history and other tests — your doctor decides what it means for you.
What this test cannot tell you
- Blocked bile flow raises CA-19-9 markedly on its own, so a value measured during jaundice reflects the obstruction as much as any tumour and is usually repeated after it has been relieved.
- A well-recognised group of people, defined by their Lewis blood group status, lack the enzyme needed to produce the antigen at all; in them the result stays low however advanced any disease might be, so the test is uninformative.
- It is not a screening test; in people without symptoms or a diagnosis it produces far more false alarms than useful findings.
- A low result carries no independent meaning and does not exclude pancreatic or biliary cancer.
Risks of the blood draw
- Mild bruising or brief soreness where the needle went in.
- Occasional lightheadedness, which settles after a few minutes of rest.
- Bleeding or infection at the site, which is rare with sterile single-use equipment.
- 1CA-19-9 is used to monitor known pancreatic and biliary cancer, not to screen for it in healthy people.
- 2Gallstones, pancreatitis, blocked bile ducts and jaundice from any cause raise it strongly with no cancer present.
- 3Some people cannot produce this antigen at all because of their blood group, so their result stays low regardless of disease.
- 4A normal value does not exclude pancreatic or biliary cancer.
- 5Serial values from the same laboratory are what carry the information, not any single figure.
Frequently Asked Questions
Everything you need to know about the CA-19.9 test. Can't find what you're looking for?
Talk to our team→No. In people without symptoms it flags far more benign conditions than cancers, and it misses cancer entirely in those who cannot produce the antigen. Its accepted uses are helping assess a mass that has already been found and following disease that has already been diagnosed.
The antigen is cleared through the bile. When bile flow is blocked, by a stone, a stricture or a tumour, it backs up into the blood and values can rise steeply for that reason alone. Doctors commonly repeat the test after a stent or drain has relieved the blockage, so that the value means something.
Producing the CA-19-9 antigen requires a particular enzyme linked to the Lewis blood group system, and a recognised group of people do not have it. In them the test stays low whatever is happening. Some tumours also simply produce very little of it.
It is generally an encouraging sign, consistent with the amount of tumour having been reduced. It is not proof that all disease has gone. Your doctor reads the trend together with imaging and how you are clinically, and continues to follow it over time rather than acting on one value.
CA-19.9 is a tumour marker commonly associated with pancreatic cancer. It can also be elevated in other gastrointestinal cancers and some non-cancerous conditions. No fasting is required.
Used to monitor pancreatic cancer treatment response, assess prognosis, and aid in the differential diagnosis of pancreatic masses.
No, fasting is not required for the Pancreatic & GI Marker test, so you can eat and drink normally beforehand.
The Pancreatic & GI Marker test uses a blood sample, collected quickly by our DHA-licensed phlebotomist with minimal discomfort.
Results for the Pancreatic & GI Marker test are typically ready within 12 hours. You will receive a secure digital report, and your Smart Report highlights anything outside the normal range.
The Pancreatic & GI Marker test is AED 230, which includes free home sample collection and a physician-reviewed report. You can also build a custom panel and pay only for the markers you choose.
Yes. A DHA-licensed phlebotomist can collect your sample at home or the office anywhere in Dubai at no extra cost, 7 days a week. See how it works.
It is commonly chosen by adults & at-risk groups. If you are not sure it is right for you, our care team is happy to advise.
Add the Pancreatic & GI Marker test to your cart and complete the short booking wizard, choosing home collection or a lab visit. Guest checkout lets you book without creating an account.
Yes. It is processed at our EIAC-accredited laboratory (ISO 15189:2022) under DHA license 0046381 and verified by board-certified pathologists.
Every report includes reference ranges and plain-language notes. If you have questions, our care team can arrange a clinician review — just get in touch.
Absolutely. Add it to a curated health package or bundle it with any of our 160+ biomarkers, often from a single sample in one visit.